C-X-C-Chemokine-Receptor-Type-4 Inhibitor AMD3100 Attenuates Pulmonary Inflammation and Fibrosis in Silicotic Mice

References

• Barnes H, Goh NSL, Leong TL., et al. Silica-associated lung disease: an old-world exposure in modern industries. Respirology. 2019;24(12):1165–1175. doi:10.1111/resp.13695
   PubMed Web of Science ®Google Scholar
• Feng F, Li N, Cheng P, et al. Tanshinone IIA attenuates silica-induced pulmonary fibrosis via inhibition of TGF-β1-Smad signaling pathway. Biomed Pharmacother. 2020;121:109586. doi:10.1016/j.biopha.2019.109586
   PubMed Web of Science ®Google Scholar
• Hoy RF, Chambers DC. Silica-related diseases in the modern world. Allergy. 2020;75(11):2805–2817. doi:10.1111/all.14202
   PubMed Web of Science ®Google Scholar
• Derlin T, Jaeger B, Jonigk D, et al. Clinical Molecular Imaging of Pulmonary CXCR4 Expression to Predict Outcome of Pirfenidone Treatment in Idiopathic Pulmonary Fibrosis. Chest. 2021;159(3):1094–1106. doi:10.1016/j.chest.2020.08.2043
   PubMed Web of Science ®Google Scholar
• Abraham M, Pereg Y, Bulvik B, et al. Single Dose of the CXCR4 Antagonist BL-8040 Induces Rapid Mobilization for the Collection of Human CD34+ Cells in Healthy Volunteers. Clin Cancer Res. 2017;23(22):6790–6801. doi:10.1158/1078-0432.CCR-16-2919
   PubMed Web of Science ®Google Scholar
• Harms M, Gilg A, Ständker L, et al. Microtiter plate-based antibody-competition assay to determine binding affinities and plasma/blood stability of CXCR4 ligands. Sci Rep. 2020;10(1):16036. doi:10.1038/s41598-020-73012-4
   PubMed Web of Science ®Google Scholar
• Wang J, Tannous BA, Poznansky MC, et al. CXCR4 antagonist AMD3100 (plerixafor): from an impurity to a therapeutic agent. Pharmacological Res. 2020;159:105010. doi:10.1016/j.phrs.2020.105010
   PubMed Web of Science ®Google Scholar
• Song JS, Kang CM, Kang HH, et al. Inhibitory effect of CXC chemokine receptor 4 antagonist AMD3100 on bleomycin induced murine pulmonary fibrosis. Exp Mol Med. 2010;42(6):465–472. doi:10.3858/emm.2010.42.6.048
   PubMed Web of Science ®Google Scholar
• Zhang H, Xiao B, Jiang L, et al. Inhibition of mesenchymal stromal cells’ chemotactic effect to ameliorate paraquat-induced pulmonary fibrosis. Toxicol Lett. 2019;307:1–10. doi:10.1016/j.toxlet.2019.01.005
   PubMed Web of Science ®Google Scholar
• Konrad FM, Meichssner N, Bury A, et al. Inhibition of SDF-1 receptors CXCR4 and CXCR7 attenuates acute pulmonary inflammation via the adenosine A2B-receptor on blood cells. Cell Death Dis. 2017;8(5):e2832. doi:10.1038/cddis.2016.482
   PubMedGoogle Scholar
• Li F, Xu X, Geng J, et al. The autocrine CXCR4/CXCL12 axis contributes to lung fibrosis through modulation of lung fibroblast activity. Exp Ther Med. 2020;19(3):1844–1854. doi:10.3892/etm.2020.8433
   PubMed Web of Science ®Google Scholar
• Peng Y, Wu Q, Tang H, et al. NLRP3 Regulated CXCL12 Expression in Acute Neutrophilic Lung Injury. J Inflamm Res. 2020;13:377–386. doi:10.2147/JIR.S259633
   PubMed Web of Science ®Google Scholar
• Zhao FY, Cheng TY, Yang L, et al. G-CSF Inhibits Pulmonary Fibrosis by Promoting BMSC Homing to the Lungs via SDF-1/CXCR4 Chemotaxis. Sci Rep. 2020;10(1):10515. doi:10.1038/s41598-020-65580-2
   PubMed Web of Science ®Google Scholar
• Ghosh MC, Makena PS, Gorantla V, et al. CXCR4 regulates migration of lung alveolar epithelial cells through activation of Rac1 and matrix metalloproteinase-2. Am J Physiol Lung Cell Mol Physiol. 2012;302(9):L846–856. doi:10.1152/ajplung.00321.2011
   PubMed Web of Science ®Google Scholar
• Chiang HY, Chu PH, Lee TH. R1R2 peptide ameliorates pulmonary fibrosis in mice through fibrocyte migration and differentiation. PLoS One. 2017;12(10):e0185811. doi:10.1371/journal.pone.0185811
   PubMed Web of Science ®Google Scholar
• Griffiths K, Habiel DM, Jaffar J, et al. Anti-fibrotic Effects of CXCR4-Targeting i-body AD-114 in Preclinical Models of Pulmonary Fibrosis. Sci Rep. 2018;8(1):3212. doi:10.1038/s41598-018-20811-5
   PubMed Web of Science ®Google Scholar
• Rajasingh J, Li C, Li X, et al. Circulating Fibrocytes Are Increased in Neonates with Bronchopulmonary Dysplasia. PLoS One. 2016;11(6):1–12. doi:10.1371/journal.pone.0157181
   Web of Science ®Google Scholar
• Sun W, Shi H, Yuan Z, et al. Prognostic Value of Genes and Immune Infiltration in Prostate Tumor Microenvironment. Front Oncol. 2020;10:584055. doi:10.3389/fonc.2020.584055
   PubMed Web of Science ®Google Scholar
• Rodrigues DAS, Prestes EB, Gama AMS, et al. CXCR4 and MIF are required for neutrophil extracellular trap release triggered by Plasmodium-infected erythrocytes. PLoS Pathog. 2020;16(8):e1008230. doi:10.1371/journal.ppat.1008230
   PubMed Web of Science ®Google Scholar
• Chrysanthopoulou A, Mitroulis I, Apostolidou E, et al. Neutrophil extracellular traps promote differentiation and function of fibroblasts. J Pathol. 2014;233(3):294–307. doi:10.1002/path.4359
   PubMed Web of Science ®Google Scholar
• Jang JW, Thuy PX, Lee JW, et al. CXCR4 promotes B cell viability by the cooperation of nuclear factor (erythroid-derived 2)-like 2 and hypoxia-inducible factor-1alpha under hypoxic conditions. Cell Death Dis. 2021;12(4):330. doi:10.1038/s41419-021-03615-w
   PubMed Web of Science ®Google Scholar
• Becker M, Hobeika E, Jumaa H, et al. CXCR4 signaling and function require the expression of the IgD-class B-cell antigen receptor. Proc Natl Acad Sci U S A. 2017;114(20):5231–5236. doi:10.1073/pnas.1621512114
   PubMed Web of Science ®Google Scholar
• Della-Torre E, Rigamonti E, Perugino C, et al. B lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease. J Allergy Clin Immunol. 2020;145(3):968–981.e914. doi:10.1016/j.jaci.2019.07.004
   PubMed Web of Science ®Google Scholar
• Eleftheriadis T, Pissas G, Zarogiannis S, et al. Crystalline silica activates the T-cell and the B-cell antigen receptor complexes and induces T-cell and B-cell proliferation. Autoimmunity. 2019;52(3):136–143. doi:10.1080/08916934.2019.1614171
   PubMed Web of Science ®Google Scholar
• Liu F, Dai W, Li C, et al. Role of IL-10-producing regulatory B cells in modulating T-helper cell immune responses during silica-induced lung inflammation and fibrosis. Sci Rep. 2016;6:28911. doi:10.1038/srep28911
   PubMed Web of Science ®Google Scholar
• Barwinska D, Oueini H, Poirier C, et al. AMD3100 ameliorates cigarette smoke-induced emphysema-like manifestations in mice. Am J Physiol Lung Cell Mol Physiol. 2018;315(3):L382–86. doi:10.1152/ajplung.00185.2018
   PubMed Web of Science ®Google Scholar
• Szarka RJ, Wang N, Gordon L, Nation PN, Smith RH. A murine model of pulmonary damage induced by lipopolysaccharide via intranasal instillation. J Immunol Methods. 1997;202:49–57. doi:10.1016/s0022-1759(96)00236-0.
   PubMed Web of Science ®Google Scholar
• Ashcroft T, Simpson JM, Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol. 1988;41(4):467–470. doi:10.1136/jcp.41.4.467
   PubMed Web of Science ®Google Scholar
• Nie Y, Wang Z, Chai G, et al. Dehydrocostus Lactone Suppresses LPS-induced Acute Lung Injury and Macrophage Activation through NF-kappaB Signaling Pathway Mediated by p38 MAPK and Akt. Molecules. 2019;24(8):1510. doi:10.3390/molecules24081510
   PubMed Web of Science ®Google Scholar
• De Clercq E. Mozobil(R) (Plerixafor, AMD3100), 10 years after its approval by the US Food and Drug Administration. Antivir Chem Chemother. 2019;27:2040206619829382. doi:10.1177/2040206619829382
   Google Scholar
• Pang J, Luo Y, Wei D, et al. Comparative Transcriptome Analyses Reveal a Transcriptional Landscape of Human Silicosis Lungs and Provide Potential Strategies for Silicosis Treatment. Front Genet. 2021;12:652901. doi:10.3389/fgene.2021.652901
   PubMed Web of Science ®Google Scholar
• Garg B, Giri B, Modi S, et al. NFkappaB in Pancreatic Stellate Cells Reduces Infiltration of Tumors by Cytotoxic T Cells and Killing of Cancer Cells, via Up-regulation of CXCL12. Gastroenterology. 2018;155(3):880–891 e888. doi:10.1053/j.gastro.2018.05.051
   PubMed Web of Science ®Google Scholar
• Sercundes MK, Ortolan LS, Debone D, et al. Targeting Neutrophils to Prevent Malaria-Associated Acute Lung Injury/Acute Respiratory Distress Syndrome in Mice. PLoS Pathog. 2016;12(12):e1006054. doi:10.1371/journal.ppat.1006054
   PubMed Web of Science ®Google Scholar
• Scalerandi MV, Peinetti N, Leimgruber C, et al. Inefficient N2-Like Neutrophils Are Promoted by Androgens During Infection. Front Immunol. 2018;9:1980. doi:10.3389/fimmu.2018.01980
   PubMed Web of Science ®Google Scholar
• Sugimoto MA. Anti-Inflammatory Potential of 1-Nitro-2-Phenylethylene. Molecules. 2017;22(11):1–12. doi:10.3390/molecules22111977
   Web of Science ®Google Scholar
• Perl M, Lomas-Neira J, Chung CS, et al. Epithelial cell apoptosis and neutrophil recruitment in acute lung injury-a unifying hypothesis? What we have learned from small interfering RNAs. Mol Med. 2008;14(7–8):465–475. doi:10.2119/2008-00011.Perl
   PubMed Web of Science ®Google Scholar
• Aratani Y. Myeloperoxidase: its role for host defense, inflammation, and neutrophil function. Arch Biochem Biophys. 2018;640:47–52. doi:10.1016/j.abb.2018.01.004
   PubMed Web of Science ®Google Scholar
• Liu Q, Li Z, Gao J-L, et al. CXCR4 antagonist AMD3100 redistributes leukocytes from primary immune organs to secondary immune organs, lung, and blood in mice. Eur J Immunol. 2015;45(6):1855–1867. doi:10.1002/eji.201445245
   PubMed Web of Science ®Google Scholar
• El-Kashef DH. Nicorandil ameliorates pulmonary inflammation and fibrosis in a rat model of silicosis. Int Immunopharmacol. 2018;64:289–297. doi:10.1016/j.intimp.2018.09.017
   PubMed Web of Science ®Google Scholar
• Alessandro M, Conticini E, Bergantini L, et al. Neutrophil Extracellular Traps in ANCA-Associated Vasculitis and Interstitial Lung Disease: a Scoping Review. Life. 2022;12(2):317. doi:10.3390/life12020317
   PubMedGoogle Scholar
• Brinkmann V, Goosmann C, Kuhn LI, et al. Automatic quantification of in vitro NET formation. Front Immunol. 2012;3:413. doi:10.3389/fimmu.2012.00413
   PubMed Web of Science ®Google Scholar
• Cargnoni A, Romele P, Bonassi Signoroni P, et al. Amniotic MSCs reduce pulmonary fibrosis by hampering lung B‐cell recruitment, retention, and maturation. Stem Cells Transl Med. 2020;9(9):1023–1035. doi:10.1002/sctm.20-0068
   PubMed Web of Science ®Google Scholar
• Ali MF, Egan AM, Shaughnessy GF, et al. Antifibrotics Modify B-Cell–induced Fibroblast Migration and Activation in Patients with Idiopathic Pulmonary Fibrosis. Am J Respir Cell Mol Biol. 2021;64(6):722–733. doi:10.1165/rcmb.2020-0387OC
   PubMed Web of Science ®Google Scholar
• Lu Y, Liu F, Li C, et al. IL-10-Producing B Cells Suppress Effector T Cells Activation and Promote Regulatory T Cells in Crystalline Silica-Induced Inflammatory Response in vitro. Mediators Inflamm. 2017;2017:8415094. doi:10.1155/2017/8415094
   PubMed Web of Science ®Google Scholar
• Chauhan PS, Wagner JG, Benninghoff AD, et al. Rapid Induction of Pulmonary Inflammation, Autoimmune Gene Expression, and Ectopic Lymphoid Neogenesis Following Acute Silica Exposure in Lupus-Prone Mice. Front Immunol. 2021;12:635138. doi:10.3389/fimmu.2021.635138
   PubMed Web of Science ®Google Scholar
• Peng M, Wang W, Qin L, et al. Association between nonspecific interstitial pneumonia and presence of CD20+ B lymphocytes within pulmonary lymphoid follicles. Sci Rep. 2017;7(1):16912. doi:10.1038/s41598-017-17208-1
   PubMed Web of Science ®Google Scholar
• Winkler IG, Bendall LJ, Forristal CE, et al. B-lymphopoiesis is stopped by mobilizing doses of G-CSF and is rescued by overexpression of the anti-apoptotic protein Bcl2. Haematologica. 2013;98(3):325–333. doi:10.3324/haematol.2012.069260
   PubMed Web of Science ®Google Scholar
• Xue J, Kass DJ, Bon J, et al. Plasma B lymphocyte stimulator and B cell differentiation in idiopathic pulmonary fibrosis patients. J Immunol. 2013;191(5):2089–2095. doi:10.4049/jimmunol.1203476
   PubMed Web of Science ®Google Scholar
• Mo F, Luo Y, Yan Y, et al. Are activated B cells involved in the process of myocardial fibrosis after acute myocardial infarction? An in vivo experiment. BMC Cardiovasc Disord. 2021;21(1):5. doi:10.1186/s12872-020-01775-9
   PubMed Web of Science ®Google Scholar
• Tai W, Zhou Z, Zheng B, et al. Inhibitory effect of circulating fibrocytes on injury repair in acute lung injury/acute respiratory distress syndrome mice model. J Cell Biochem. 2018;119(10):7982–7990. doi:10.1002/jcb.26664
   PubMed Web of Science ®Google Scholar
• Heukels P, van Hulst JAC, van Nimwegen M, et al. Fibrocytes are increased in lung and peripheral blood of patients with idiopathic pulmonary fibrosis. Respir Res. 2018;19(1):90. doi:10.1186/s12931-018-0798-8
   PubMed Web of Science ®Google Scholar
• Li J, Yao W, Hou JY, et al. The Role of Fibrocyte in the Pathogenesis of Silicosis. Biomed Environ Sci. 2018;31(4):311–316. doi:10.3967/bes2018.040
   PubMed Web of Science ®Google Scholar
• Desai O, Winkler J, Minasyan M, et al. The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis. Front Med. 2018;5:43. doi:10.3389/fmed.2018.00043
   PubMed Web of Science ®Google Scholar